Myocardial infarction, one of the main factors that threatens human health, leads to cardiac cell death. Myocardial cells suffer ischemia and hypoxia for a long period of time, which can lead to irreversible cell death or apoptosis and cardiac dysfunction. MicroRNAs (miRs) have been reported to play an important role in a wide range of biological processes in cardiac myocytes, which respond to inflammation and oxidative stress. The aim of the present study was to investigate the effect of miR-370 on oxidative stress and apoptosis of cardiac myocytes in ischemic H9C2 cells induced by hydrogen peroxide (H 2 O 2 ). H9C2 cells were cultured and treated with different concentrations of H 2 O 2 solution. Then, cells were transfected with miR-370 mimic or negative control (NC) mimic, small interfering (si)-RNA-Forkhead box O1 (FOXO1) and NC siRNA. A Cell Counting Kit-8 and flow cytometry assay were conducted to detect cell viability and cell apoptosis. The expression of oxidative stress associated factors were detected by ELISA. The levels of miR-370 and FOXO1 were examined using western blotting and reverse transcription-quantitative PCR. A luciferase reporter gene assay was performed to verify whether FOXO1 was a target gene of miR-370. The results revealed that miR-370 expression was downregulated and FOXO1 expression was increased in H9C2 cells induced by H 2 O 2 . Additionally, FOXO1 was proven to be a target of miR-370. The ELISA and flow cytometry assay revealed that miR-370 overexpression and FOXO1 silencing reversed H 2 O 2 -induced oxidative stress and apoptosis. The results indicated that miR-370 could inhibit the oxidative stress and apoptosis of H9C2 cells induced by H 2 O 2 by targeting FOXO1. Therefore, miR-370 may be a new therapeutic target for ischemic heart disease.
Introduction
Cardiovascular disease has the highest rates of morbidity and mortality worldwide (1), as it results in cardiac remodeling which is associated with the potential pathological changes observed in most heart diseases, including heart failure, myocardial infarction (MI), atrial fibrillation, atherosclerosis (AS) and ischemia/reperfusion (IR) (2) . MI is one of the main factors that threatens human health and causes cardiac cell death (3) . During MI, myocardial cells suffer ischemia and hypoxia for a long period of time, which can lead to irreversible
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cell death or apoptosis and cardiac dysfunction (4) . Reducing apoptosis of myocardial cells can improve cardiac function and cardiac remodeling process after MI (5) .
Oxidative stress and apoptosis play a crucial role in the development of cardiovascular diseases (6) . The balance between oxidants and antioxidants plays a vital role in maintaining normal biological function. Excessive levels of reactive oxygen species cause serious damage to cardiac myocytes, which can damage the oxidation-antioxidant equilibrium system (7) . In addition, further damage can lead to apoptosis (8) . Therefore, mitigation of oxidative stress and direct intervention in inhibiting apoptotic pathways can provide potential molecular targets for treatment (9, 10) .
MicroRNAs (miRs/miRNAs) are a class of non-coding RNA molecules, 18-24 nucleotides long, that are endogenous, conserved and can degrade or inhibit the translation of their target mRNAs, thereby regulating gene expression and playing an important role in a wide range of biological processes (11) (12) (13) . There is an increasing body of evidence that has indicated the important role of miRNAs in a number of types of cardiac diseases (14) (15) (16) . Although the functions of miR-370 in different diseases are controversial, miR-370 has always been considered to be a tumor suppressor in a number of types of human cancers. For example, miR-370 was downregulated in endometrioid ovarian cancer by regulating endoglin to suppress cell proliferation and induce cell apoptosis (17) . Feng et al (18) illustrated that there was significant downregulation of miR-370 in gastric cancer tissues and cells targeting progestin and AdipoQ receptor family member 4. It has been reported that the expression of miR-370 was decreased in AS models and upregulation of miR-370 could inhibit vascular inflammation and oxidative stress (19) . Furthermore, the expression of miR-370 in the myocardium was reported to decrease after MI (20) . However, the expression of miR-370 in cardiac myocytes after induction with hydrogen peroxide (H 2 O 2 ) and the corresponding mechanisms on oxidative stress and apoptosis have not been studied.
H 2 O 2 has been extensively used to induce an apoptotic response in different cell types and the H9C2 cell line is frequently used to study oxidative stress induced cardiomyocyte apoptosis (21) . Therefore, the aim of this present study was to investigate the effect of miR-370 on H 2 O 2 -induced myocardial damage in H9C2 cells via oxidative stress and apoptosis.
Materials and methods
Cell culture and treatment. The H9C2 cardiomyocytes were purchased from the American Type Culture Collection. Cells were cultivated in 10% fetal bovine serum (FBS; Beyotime Institute of Biotechnology) and 1% penicillin/streptomycin DMEM (Beyotime Institute of Biotechnology) and incubated at 37˚C in an atmosphere containing 5% CO 2 . The cells were subjected to H 2 O 2 (50, 100 and 200 µM; Merck KGaA) solution in DMEM without FBS treatment for 4 h.
Cell transfection. H9C2 cells were seeded into 12-well plates with 1x10 6 cells/well and cultured in serum-free DMEM at 37˚C with 5% CO 2 continuously to ensure that cell confluence reached 80% before transfection.
According to the manufacturer's protocol, miR-370 mimics (cat. no. miR10000722-1-5), negative control (NC) mimic (cat. no. miR1190315051351), small interfering RNA (siR-/siRNA)-Forkhead box O1 (FOXO1)-1 (5'-GGA CA ACA ACA GTA AAT TT-3'), siR-FOXO1-2 (5'-GCA CCG ACT TTA TGA GCA A-3') and NC siRNA (cat. no. siT0000003-1-5) (Each, 100 nM; all, Guangzhou RiboBio Co., Ltd.) were transfected into H9C2 cells for 48 h using Lipofectamine 2000™ reagent (Invitrogen; Thermo Fisher Scientific, Inc.).
Cell viability assay. Cell Counting Kit-8 (CCK-8; Dojindo Molecular Technologies, Inc.) was used to assess cardiomyocyte viability. After H9C2 cells were treated with H 2 O 2, 10 µl CCK-8 solution was added to each well and the cells were incubated at 37˚C for 4 h. Finally, the optical density of each well was measured at a wavelength of 490 nm using a plate reader (Infinite ® 200 PRO NanoQuant; Tecan Group, Ltd. Flow cytometry assay. Cell apoptosis was evaluated using an Annexin V-FITC Apoptosis Detection kit (BD Biosciences; Becton, Dickson and Company) in accordance with the manufacturer's protocol. The cells were treated as described above. All adhering and floating cells were harvested, washed twice with PBS, transferred into sterile centrifuge tube and then stained successively with propidium iodide (10 µl) and Annexin-V-FITC (10 µl; Nanjing KeyGen Biotech Co., Ltd.) for 15 min at 37˚C. A flow cytometer (BD Biosciences; Becton, Dickson and Company) was used to assess apoptotic cells and data were analyzed using CellQuest software (version 3.1, BD Biosciences). Experiments were repeated three times independently.
Reverse transcription-quantitative PCR (RT-qPCR).
Total RNA was extracted from cells using TRIzol reagent (Thermo Fisher Scientific, Inc.). Then, the total RNA was used to synthesize cDNA using a PimeScript RT master mix kit (Takara Biotechnology Co., Ltd.) following the manufacturer's protocol. The RT conditions were as follows: 10 min at 25˚C, 30 min at 45˚C and 5 min at 95˚C. qPCR was performed with the following thermocycling condition: 95˚C for an initial 10 min followed by 40 cycles of denaturation for 15 sec at 95˚C, annealing at 60˚C for 30 sec and extension at 72˚C for 30 sec with the SYBR Premix Ex Taq (Applied Biosystems; Thermo Fisher Scientific, Inc.). Fold-changes of miR-370 and mRNA levels were calculated using the 2 -ΔΔCq method (22) . U6 and GAPDH were used as the endogenous controls. The following primers were used: GAPDH forward, 5'-AGA CAG CCG CAT CTT CTT GT-3' and reverse, 5 '-TGA TGG CAA CAA  TGT CCA CT-3'; U6 forward, 5'-CTC GCT TCG GCA GCA  CA-3', and reverse, 5'-AAC GCT TCA CGA ATT TGC GT-3';  miR-370 forward, 5'-TAC TCA GGA TCC TGT GCA AGG CGG  GCT ACT-3' and reverse, 5'-TAC TCA AAG CTT CCC TCC CTC  ACC CAA ATC-3'; FOXO1 forward, 5'-AGG ATC CGA TGT  CAC CAT GGC CG-3' and reverse, 5'-AAA GGA TCC ACC ATG GCC G-3'.
Western blot analysis. The total proteins from cells were isolated using RIPA lysis buffer (Beyotime Institute of Biotechnology) and the concentration of protein was measured with a bicinchoninic acid kit (Beyotime Institute of Biotechnology). Subsequently, an equal quantity of proteins (20 µg) was separated by 10% SDS-PAGE and then transferred onto polyvinylidene fluoride membranes (EMD Millipore). Then the membranes were blocked with 5% non-fat dry milk for 1 h at room temperature. After washing, the membranes were incubated with primary antibodies against FOXO1 (1:1,000; cat. no. 2880) and GAPDH (1:2,000; cat. no. 5174) from Cell Signaling Technology, Inc. at 4˚C overnight and washed with 0.1% Tris-Buffered Saline with Tween 20, followed by incubation with horseradish peroxidase conjugated secondary antibodies (1:3,000; cat. no. ab214880; Abcam) for 1 h at room temperature. Blots were developed using an enhanced chemiluminescence film kit (Perkin Elmer, Inc.) and the images were analyzed using ImageJ software (version 1.8.0; National Institutes of Health). All experiments were repeated three times independently.
Dual luciferase reporter assays. The online bioinformatics tool, TargetScan (http://www.targetscan.org/vert_71/), was used to predict the possible binding targets of miR-370 and FOXO1. A fragment of the FOXO1-3' untranslated region (UTR) containing the miR-370 predicted seed region (wild-type; WT) was amplified from the cDNA of cells and inserted into pGL-3 plasmids (Promega Corporation). The H9C2 cells were co-transfected with the WT 3'UTR of FOXO1 containing the miR-370 binding sites and mutant FOXO1 3'UTR with NC mimics or miR-370 mimics using Lipofectamine 2000™ (Thermo Fisher Scientific, Inc.). Luciferase activity was measured by the Dual Luciferase Reporter Assay system (Promega Corporation), normalizing to Renilla luciferase activity. All experiments were repeated three times independently.
Statistical analysis. All data were presented as the mean ± standard deviation. SPSS v20.0 software (IBM Corp.) was used to analyze the data. Additionally, a Student's t-test was used to determine differences between two groups, while one-way analysis of variance followed by the Dunnett's post hoc test were used for multiple comparisons. P<0.05 was considered to indicate a statistically significant difference.
Results
Cell viability and the expression of miR-370 are inhibited by H 2 O 2 in cardiomyocytes. The H9C2 cells were treated with H 2 O 2 at different concentrations (0, 50, 100 and 200 µmol/l) for 4 h. Then, the cell viability was detected using a CCK-8 assay. As shown in Fig. 1 , when compared with the control (0 µmol/l H 2 O 2 ) group, the activity of H9C2 cells treated with oxidative stress was concentration dependent and cell viability significantly decreased with the increasing concentration (P<0.01). A dose of 100 µmol/l (cell viability, 50%) was selected for subsequent experiments.
miR-370 overexpression attenuates H 2 O 2 -induced oxidative stress and apoptosis in H9C2 cells. The H 2 O 2 -induced H9C2 cells were transfected with the miR-370 mimic or NC mimic vectors. Subsequently, RT-qPCR was performed to detect the expression levels of miR-370. As shown in Fig. 2A , the expression of miR-370 was significantly decreased in the H 2 O 2 -induced H9C2 cells when compared with the normal H9C2 cells (P<0.001); however, the expression of miR-370 was significantly increased in H9C2 cells transfected with miR-370 mimic when compared with the NC mimic group (P<0.001; Fig. 2A ). The results indicated that miR-370 expression could be inhibited by H 2 O 2 in H9C2 cells, which in turn suggested that miR-370 may be downregulated in myocardial cells with ischemia and hypoxia.
To verify miR-370 function in oxidative stress and apoptosis, an ELISA was used to detect SOD, MDA and LDH levels in the supernatant, and a flow cytometry assay was used to detect apoptosis. As exhibited in Fig. 2B , when compared with the control group, SOD expression significantly decreased (P<0.001) and MDA and LDH expression significantly increased in the H 2 O 2 and NC mimic groups (P<0.01). Compared with the H 2 O 2 and NC mimic groups, SOD expression increased, and MDA and LDH expression reduced in the miR-370 mimics group. Furthermore, the results of flow cytometry revealed that the rate of apoptosis was significantly increased in the H 2 O 2 and NC mimic groups when compared with the control group (P<0.001; Fig. 2C and D) . Compared with the H 2 O 2 and NC mimic groups, the rate of apoptosis was decreased in the miR-370 mimics group. These findings suggested that the overexpression of miR-370 could markedly suppress the oxidative stress and apoptosis induced by H 2 O 2 . Luciferase reporter assay for target verification. The results of the online bioinformatics tool TargetScan suggested that FOXO1 was predicted to be a possible target gene of miR-370.
A luciferase reporter assay was conducted to verify this prediction. As shown in Fig. 3 , the 3'-UTR of the gene FOXO1 was shown to contain the binding sequences for miR-370, suggesting that FOXO1 may be a downstream target gene of miR-370. Luciferase activity was significantly reduced in the FOXO1 3'UTR WT group transfected with miR-370-3p mimics (P<0.001), whereas there was no variation in the mutant-type FOXO1 3'UTR, therefore also suggesting that FOXO1 may be a direct target gene of miR-370.
FOXO1 expression is increased in H 2 O 2 -induced H9C2 cells.
The mRNA and protein levels of FOXO1 were measured by RT-qPCR and western blotting assay. As shown in Fig. 4A and B, the expression of FOXO1 was markedly increased in the H 2 O 2 and NC mimic groups when compared with the control group. Compared with the H 2 O 2 and NC mimic groups, FOXO1 expression was decreased in the miR-370 mimic group. Then, the interference efficiency of FOXO1 siRNA plasmids was detected using RT-qPCR and western blot assays. As shown in Fig. 4C and D, the expression of FOXO1 was significantly reduced in the siR-FOXO-1 and siR-FOXO1-2 groups when compared with the NC siRNA group (P<0.001). The siR-FOXO1-1 plasmid with the best interference effects was selected for subsequent experiments.
FOXO1 silencing inhibits oxidative stress and apoptosis in H 2 O 2 -induced H9C2 cells.
ELISA was used to detect the levels of SOD, MDA and LDH in the supernatant, and a flow cytometry assay was used to detect apoptosis in H 2 O 2 -induced H9C2 cells. As shown in Fig. 5A , compared with the control group, the level of SOD significantly decreased (P<0.001) and the levels of MDA and LDH were significantly increased in the H 2 O 2 and NC siRNA groups (P<0.001). However, compared with the H 2 O 2 and NC siRNA groups, SOD expression significantly increased (P<0.01), and MDA and LDH expression significantly decreased in the siR-FOXO1-1 group (P<0.01). The results of flow cytometry revealed that the rate of apoptosis was significantly increased in the H 2 O 2 and NC siRNA groups when compared with the control group (P<0.001; Fig. 5B and C) . In addition, compared with the H 2 O 2 and NC siRNA groups, the rate of apoptosis was significantly decreased in the siR-FOXO1-1 group (P<0.01). These results suggested that knockdown of FOXO1 could markedly suppress the oxidative stress and apoptosis of H9C2 cells induced by H 2 O 2 .
Discussion
The results of the present study revealed that the expression of miR-370 was decreased in H 2 O 2 -induced H9C2 cells. In addition, miR-370 overexpression attenuated H 2 O 2 -induced oxidative stress and apoptosis in H9C2 cells. Nevertheless, the underlying mechanism of miR-370 in ischemic heart disease remains largely unknown. In vitro experiments are required to further explore the effect of miR-370, in order to provide the theoretical basis for the research.
After maturation, miRNA can regulate gene expression via complementation with target mRNA and regulating cell differentiation proliferation, metabolism, and apoptosis (23) (24) (25) (26) . It has been indicated that miR-370 is involved in various types of heart diseases (27, 28) . A number of studies have published their results on miR-370 in cardiovascular diseases; however, the results are controversial. A previous study reported that miR-370 was significantly higher in patients with coronary artery disease (29) . Additionally, miR-370 was reported to be upregulated in peripheral blood mononuclear cells of coronary AS patients (30) . By contrast, miR-370 has also been found to have a positive effect in different diseases. Consistent with a previous study, the expression level of miR-370 markedly decreased in AS mouse models and oxidized low-density lipoprotein incubated THP-1 cells, and miR-370 overexpression inhibited vascular inflammation and oxidative stress (19) . In myocardial remodeling, the expression of miR-370 in the infarct border area was decreased after MI, but myocardial fibrosis was suppressed through the intervention of miR-370 (20) . The positive role of miR-360 is consistent with the results of the present study, the expression of miR-370 was markedly decreased in H9C2 cells induced by H 2 O 2 .
In the present study, H 2 O 2 had proapoptotic effects on H9C2 cells. Hypoxia is the main cause of ischemic heart disease which leads to autophagy and apoptosis through the activation of a caspase cascade via the release of cytochrome c from the mitochondria to the cytoplasm (31) . H 2 O 2 activated oxidative stress through the downregulation of SOD levels and upregulation of MDA and LDH levels in the present study. In addition, H 2 O 2 induced apoptosis by downregulating Bcl-2 and upregulating the expression of proapoptotic proteins, such as Bax, caspase-8, and cleaved-caspase-3 (32) . Oxidative stress and apoptosis are involved in cardiovascular diseases. For example, the overexpression of miRNA-132 increased the anti-oxidative stress and anti-apoptotic abilities of H9C2 cells in heart failure (33) . The present study demonstrated that overexpression of miR-370 suppressed the oxidative stress and apoptosis induced by H 2 O 2 .
FOXO1 is an essential regulator of endothelial cell proliferation and can be modulated by a number of signaling pathways (34) . In osteoblasts, FOXO1 expression was increased when induced by H 2 O 2 (35) . Therefore, the present study speculated that FOXO1 may also be involved in the apoptosis of cardiac myocytes induced by oxidative stress. TargetScan analysis suggested that transcription factor FOXO1 was a possible target gene of miR-370. As the results demonstrated, FOXO1 expression was increased in H9C2 cells induced by H 2 O 2 . Furthermore, FOXO1 silencing suppressed H 2 O 2 -induced oxidative stress and apoptosis in H9C2 cells. These results indicated that FOXO1 was involved in H 2 O 2 -induced oxidative stress and apoptosis, which was consistent with the hypothesis of the present study.
However, some limitations should be considered in the present study, the H9C2 cells are not mature cardiomyocytes and only an in vitro model, which does not entirely explain the results in physiological and pathological processes. Therefore, future studies will be needed to confirm the present results in IR with in vivo models.
In conclusion, the results of the present study indicate that FOXO1 was a target gene of miR-370, and miR-370 reduced H 2 O 2 -induced oxidative stress and apoptosis in H9C2 cells by targeting FOXO1, which provides a theoretical basis for the treatment of ischemic heart disease. 
